Overview of Losartan Potassium
Losartan Potassium is a widely used antihypertensive drug belonging to the class of angiotensin II receptor blockers (ARBs). It is primarily used to treat high blood pressure (hypertension) and certain types of heart conditions by relaxing blood vessels and improving blood flow[2].
Current Market Size and Growth Projections
As of 2024, the global Losartan market is valued at approximately USD 1625.5 million. This market is expected to grow at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031, reaching a projected value of USD 2212.1 million by 2031[3].
Regional Market Breakdown
- North America: This region holds the largest market share, with a market size of USD 650.2 million in 2024. It is expected to grow at a CAGR of 2.7% from 2024 to 2031[3].
- Europe: Europe accounts for more than 30% of the global revenue, with a market size of USD 487.65 million in 2024. It is projected to grow at a CAGR of 3.0% from 2024 to 2031[3].
- Asia-Pacific: This region holds around 23% of the global revenue, with a market size of USD 373.87 million in 2024. It is expected to grow at a CAGR of 6.5% from 2024 to 2031, making it one of the fastest-growing regions[3].
Losartan Potassium API Market
The global Losartan Potassium Active Pharmaceutical Ingredient (API) market is valued at USD 1652.2 million in 2024 and is anticipated to grow at a CAGR of 5.50% from 2024 to 2031, reaching USD 2403.42 million by 2031[4].
Regional API Market Breakdown
- North America: Holds more than 40% of the global API market revenue, with a market size of USD 660.88 million in 2024, and is expected to grow at a CAGR of 3.7% from 2024 to 2031[4].
- Europe: Accounts for more than 30% of the global API market revenue, with a market size of USD 495.66 million in 2024, and is projected to grow at a CAGR of 4.0% from 2024 to 2031[4].
- Asia-Pacific: Holds around 23% of the global API market revenue, with a market size of USD 380.01 million in 2024, and is expected to grow at a CAGR of 7.5% from 2024 to 2031[4].
Price Projections for Losartan Potassium
Current Price Trends
In December 2024, the global market for Losartan Potassium is expected to experience a significant price decline. This drop is driven by several factors, including softening demand, stable manufacturing output, and favorable supply chain conditions. Additionally, the clearance of older inventories as the year ends will further contribute to the downward pressure on prices[1].
Factors Influencing Price Decline
- Improved Production Capacity: China's manufacturing sector has seen a steady expansion, with the Purchasing Managers' Index (PMI) reaching 50.3 in November 2024. This increase in manufacturing output is expected to result in an oversupply of Losartan Potassium, pushing prices downward globally[1].
- Economic Conditions: Economic downturns in regions like Germany and high inflation in the Eurozone are leading to cautious consumer sentiment, reducing demand for Losartan Potassium and contributing to lower prices[1].
- Geopolitical Tensions: Potential U.S. trade threats, including additional tariffs on Chinese goods, could disrupt China’s industrial sector and further weaken demand from the U.S. market, exacerbating the downward pressure on prices[1].
Demand Drivers
Rising Geriatric Population
The increasing geriatric population is a significant driver of the demand for Losartan Potassium. As individuals age, the risk of developing hypertension rises substantially, making Losartan a crucial medication for managing age-related health issues. Studies have shown that Losartan not only regulates blood pressure but also enhances physical function and decreases frailty scores in older adults[3].
Affordability and Generic Versions
The availability of generic versions of Losartan has made hypertension management more affordable for patients, increasing its accessibility to a broader population. This affordability factor has a significant impact on the demand for Losartan, especially in regions with limited healthcare resources[2].
Market Challenges
Side Effects and Tolerability
The side effects and tolerability of Losartan can be a significant factor hindering its demand and use among some individuals. While Losartan is generally well-tolerated, some patients may experience side effects that could affect its prescription rates[2].
Geographical Trends
North America
North America dominates the Losartan market, driven by a high prevalence of hypertension and a sizable elderly population. The region's robust healthcare infrastructure and increased awareness of cardiovascular health also contribute to the strong demand for Losartan[3].
Asia-Pacific
The Asia-Pacific region is expected to make significant gains due to its large population and the increasing prevalence of cardiovascular disorders and high blood pressure. This region is projected to have the highest CAGR for both the Losartan and Losartan Potassium API markets[3][4].
Key Takeaways
- The global Losartan market is valued at USD 1625.5 million in 2024 and is expected to grow at a CAGR of 4.50% from 2024 to 2031.
- The Losartan Potassium API market is valued at USD 1652.2 million in 2024 and is expected to grow at a CAGR of 5.50% from 2024 to 2031.
- Prices for Losartan Potassium are expected to decline in December 2024 due to softening demand, stable manufacturing output, and favorable supply chain conditions.
- The rising geriatric population and the availability of generic versions are key drivers of demand for Losartan Potassium.
- North America and the Asia-Pacific region are expected to be significant markets for Losartan and its API.
FAQs
What are the primary factors driving the demand for Losartan Potassium?
The primary factors driving the demand for Losartan Potassium include the rising geriatric population and the availability of generic versions, which have made hypertension management more affordable.
Why are Losartan Potassium prices expected to drop in December 2024?
Losartan Potassium prices are expected to drop in December 2024 due to softening demand, stable manufacturing output, favorable supply chain conditions, and the clearance of older inventories.
Which regions dominate the Losartan and Losartan Potassium API markets?
North America dominates both the Losartan and Losartan Potassium API markets, while the Asia-Pacific region is expected to experience significant growth due to its large population and increasing prevalence of cardiovascular disorders.
What is the impact of geopolitical tensions on the Losartan market?
Potential U.S. trade threats, including additional tariffs on Chinese goods, could disrupt China’s industrial sector and further weaken demand from the U.S. market, exacerbating the downward pressure on Losartan prices.
How does the affordability of generic Losartan affect its market?
The availability of generic versions of Losartan has made hypertension management more affordable, increasing its accessibility to a broader population and driving demand, especially in regions with limited healthcare resources.
Sources
- ChemAnalyst, "December Forecast: Losartan Potassium Prices to Drop Due to Market Surplus," December 2, 2024.
- TechSci Research, "Losartan Market By Share, Size and Forecast 2028," 2024.
- Cognitive Market Research, "Losartan Market Report 2024," November 14, 2024.
- Cognitive Market Research, "Losartan Potassium API Market Report 2024," October 9, 2024.
- Statista, "Losartan out-of-pocket cost U.S. 2004-2022," November 5, 2024.
